Sale!

POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POMT2 gene plays a crucial role in the development and maintenance of muscle tissue. Mutations in this gene can lead to a specific form of muscular dystrophy known as Dystroglycanopathy, particularly the Limb-Girdle Type C2. This condition is characterized by progressive weakness and wasting of the limb muscles, among other symptoms. Early diagnosis is key to managing the symptoms and improving the quality of life for those affected.

DNA Labs UAE offers a genetic test specifically designed to detect mutations in the POMT2 gene. This test is a vital tool for diagnosing Dystroglycanopathy Limb-Girdle Type C2, enabling healthcare professionals to devise a tailored management plan for the patient. The test is conducted with a sample of the patient’s DNA, usually obtained through a blood draw.

The cost of the POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C2 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of an accurate diagnosis cannot be overstated, as it opens the door to targeted treatments and interventions. This test is an investment in the patient’s health and well-being, providing crucial information for managing this genetic condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C2 Genetic Test

Are you concerned about muscular dystrophy-dystroglycanopathy limb-girdle type C2? DNA Labs UAE offers the POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C2 Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle) Type C2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle) Type C2.

Test Details

The POMT2 gene is associated with a type of muscular dystrophy called limb-girdle muscular dystrophy-dystroglycanopathy, type C2 (LGMD-C2). This genetic disorder affects the muscles, causing progressive muscle weakness and wasting, particularly in the muscles of the shoulders, upper arms, and hips.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic mutations that may be causing a particular disorder or condition. In the case of LGMD-C2, NGS genetic testing can be used to detect mutations in the POMT2 gene. This can help in confirming a diagnosis, identifying carriers of the condition, and providing genetic counseling for affected individuals and their families.

It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.

Test Name POMT2 Gene Muscular dystrophy-dystroglycanopathy limb-girdle type C2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POMT2 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C2
Test Details

The POMT2 gene is associated with a type of muscular dystrophy called limb-girdle muscular dystrophy-dystroglycanopathy, type C2 (LGMD-C2). This genetic disorder affects the muscles, causing progressive muscle weakness and wasting, particularly in the muscles of the shoulders, upper arms, and hips.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic mutations that may be causing a particular disorder or condition. In the case of LGMD-C2, NGS genetic testing can be used to detect mutations in the POMT2 gene. This can help in confirming a diagnosis, identifying carriers of the condition, and providing genetic counseling for affected individuals and their families.

It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.